Skip to main content

Table 1 Literature research: databases, search terms and search combinations (see Methods section). Within the frame of this review, this database was used for experimental studies (in vitro and in vivo)

From: Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)

Database

Date

Keyword A

Keyword B

N

Web of Sciences

08.06.2021

PFAS

immune*, TDAR*, TIAR*, TIAR*, SRBC*, IgG*, IgE*, Host infection studies, viral infection, bacterial infection, innate immunity, hypersensitivity, B-cell function, plasma cell function, lymphotoxicity, Lym*, thymus atrophy, thymu*, spleen atrophy, spleen*, thymus cellularity, spleen cellularity, PPAR*

88

Web of Sciences

09.06.2021

PFAS

natural killer cell, cytokine*, IL-1R1*, IL-1Ra*, interleukin*, NF-kB*, macrophage*, mast cells, histamine*, hexosaminidase*, IFN-gamma*, T-cell, reactive oxygen species, mitochondria*, apoptosis*, host infection, inflammasome*, Nrf-2*, Nrf2*, NFAT*, calci*, neopterin*, tryptophan*, glucocorticoid*, JAK3*, p53*, Bax*, superoxiddismutase*, superoxid*, glutathion*, GST*, lipid peroxidation, caspase*, BcL-2*, BcL2*, fatty acid metabolism, innate immunity, hypersensitivity, asthma*, allerg*, respiratory infection, autoimmunity

185

Web of Sciences

23.06.2021

perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

TDAR*, TIAR*, SRBC*, KLH*, HRBC*, “host infection”, T-cell, infect*,

3

PubMed

10.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

immune, TDAR, T-cell, TIAR, SRBC, IgG, IgE, “host infection”, “viral infection”, “bacterial infection”, “innate immunity”, hypersensitivity

192

PubMed

11.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

B-cell, “plasma cell function”, lymphotoxicity, “thymus atrophy”, “spleen atrophy”, “thymus cellularity”, “spleen cellularity”, PPAR, “natural killer”, cytokines

192

PubMed

12.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

cytokines, interleukin, NF-kB, macrophage, “mast cells”, histamine, hexosaminidase, IFN-gamma,

108

PubMed

13.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

“reactive oxygen species”, mitochondria, apoptosis, inflammasome, Nrf-2, Nrf2, NFAT, calcium, neopterin, tryptophan, “glucocorticoid receptor”, JAK3, p53, Bax, “superoxid dismutase”, glutathione, “GSH-transferase”, GST,

187

PubMed

14.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

Inflammasome, Nrf-2, Nrf2, NFAT, calcium, neopterin, tryptophan, “glucocorticoid receptor”, JAK3, p53, Bax, “superoxid dismutase”, “glutathione”, “GSH-transferase”, GST,

191

PubMed

15.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

“lipid peroxidation”, caspase

41

PubMed

17.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

BcL-2, BcL2, “fatty acid metabolism”, “innate immunity”, hypersensitivity, asthma

116

PubMed

18.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

asthma, allergies, “respiratory infection”, autoimmunity,

160

PubMed

20.06.2021

PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

infection

141

Scopus

08/09.07.2021

perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX*

immune*, TDAR*, TIAR*, SRBC*, KLH*, HRBC*, PPAR*, infect*, T-cell*, antibod*

80

  1. Please see also List of Abbreviations, for description of Table see Methods section